Jiong Zhao to Cell Line, Tumor
This is a "connection" page, showing publications Jiong Zhao has written about Cell Line, Tumor.
Connection Strength
0.097
-
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. Proc Natl Acad Sci U S A. 2022 01 25; 119(4).
Score: 0.034
-
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer. J Med Chem. 2017 02 23; 60(4):1325-1342.
Score: 0.024
-
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer. J Med Chem. 2016 Jan 14; 59(1):219-237.
Score: 0.022
-
Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 2011 Feb 28; 301(2):185-92.
Score: 0.016